We can enhance the anti-tumour capacities of neutrophils by interfering with innate immune inhibitory checkpoints to restore antibody-mediated anti-tumour activities, by targeting proteins downstream of the inhibitory receptor, by using IgA-based therapeutic mAbs that bind to the activating Fc receptors, and by modifying the Fc region of IgG therapeutic antibodies that increases affinity to Fc receptors, as shown in Figure 6 (53)
AD mostly affects those over 65 years of age, however, people in their late forties can develop the prodromal stage of AD- mild cognitive impairment (MCI)
A controlled clinical trial comparing the diuretic furosemide and hydrochlorothiazide
Vitamin C is generally safe, but excessive intake can lead to gastrointestinal discomfort
Glutathione S-transferase polymorphisms and their biological consequences
The beneficial role of Nrf2 in the endothelial dysfunction of atherosclerosis